Graft vs Host Disease

Co-Pay Relief Program Fund Notices

Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!

Get Notified


This fund has been developed in response to patients who have contacted PAF for help with their medication expenses and could not find help. While this fund has been fully designed and we are ready to provide needed support to these patient communities, this fund is not yet able to accept applications for assistance as we are still working to secure charitable donations that will allow us to open it.

If you, or someone you know, would like to contribute to this fund, please visit our Donors page for more information on how to provide critical support for patients in need.

Fund Type

  • Co-pay, Co-insurance & Deductibles
  • Office visits and administration charges related to treatment
  • Medical Insurance premiums

Maximum Award Level

$5,500 Per Year

Eligibility Requirements
  • Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
  • Insurance Requirements All Insurance Types
  • Must reside and receive treatment in the United States.

About Graft vs Host Disease

Graft-versus-host disease (GvHD) are multisystem disorders that are common complications of bone marrow and stem cell transplants in which T cells of the non-identical donated cells (the graft) recognize the transplant recipient’s body as foreign (the host), initiating an immune reaction attacking the host’s tissues. GvHD is seen most often in cases where the blood marrow donor is unrelated to the patient or when the donor is related to the patient, but not a perfect match.

There are two forms of GvHD, acute and chronic. Classic Acute GvHD (aGvHD) typically occurs within the first 100 days after a transplant. The skin, liver, and gastrointestinal tract are principal target organs in acute GvHD. It’s called Late Acute GvHD when it develops 3 or more months after transplant, but diagnostic features of chronic GvHD are absent. Chronic or Classic GvHD (cGvHD) may present any time post- transplant, but typically occurs within 1 year of the transplant. Chronic GvHD can affect the mouth, skin, nails, scalp and body hair, gastrointestinal tract, lungs, liver, muscles and joints, or genitalia. It’s called Overlap Chronic GVHD when signs and symptoms of chronic and acute GVHD appear together. Up to 70 percent of transplant recipients develop acute GVHD, which crops up within the first few months of transplantation. And 40 percent get chronic GVHD, which can evolve from acute GVHD or appear on its own and is often more severe and can last for years.

Graft vs Host Disease Resources
Medication & Financial Assistance Resources
The Patient Advocate Foundation's (PAF) Co-Pay Relief (CPR) Program does not review the information contained on the website links provided for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions as outlined on the accessed websites. PAF Co-Pay Relief Program makes no representation as to the accuracy or any other aspect of the information contained on any website accessed from the CPR website, nor does PAF Co-Pay Relief Program necessarily endorse the website information provided. The information presented on the PAF Co-Pay Relief website is provided for general information only and is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you acquire from this or any other website accessed through the PAF Co-Pay Relief program website.